We are 2-[2-(2-{[(9H-Fluoren-9-ylmethoxy)carbonyl]-amino}acetamido)acetamido]acetic acid CAS:170941-79-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
Chemical Name: 2-[2-(2-{[(9H-Fluoren-9-ylmethoxy)carbonyl]-amino}acetamido)acetamido]acetic acid
CAS.NO: 170941-79-4
Molecular Formula:C21H21N3O6
Molecular Weight:411.40800
Synonyms:
2-[[2-[[2-(9H-fluoren-9-ylmethoxycarbonylamino)acetyl]amino]acetyl]amino]acetic acid
Glycine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]glycylglycyl-
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]glycylglycylglycine
1-(9H-Fluoren-9-yl)-3,6,9-trioxo-2-oxa-4,7,10-triazadodecan-12-oic acid
Fmoc-Gly-Gly-Gly
Fmoc-Gly-Gly-Gly-OH
Physical and Chemical Properties:
Density: 1.4±0.1 g/cm3
Boiling point:811.8±65.0 °C at 760 mmHg
Melting point: /
Flash point:444.8±34.3 °C
Refractive index:1.609
Specification:
Appearance: White Crystalline Powder
Purity:≥98%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store at -15ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:pharmaceutical intermediates.
Related News: Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.1-Bromo-6-fluorohexane Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.68797-94-4/8052-41-3 Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL.(2S)-2-[[(2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethylbutanoic acid China has asked the European Union for help in buying urgently needed medical supplies from its member countries, the China’s official Xinhua news agency said on Saturday.DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation.
Product Name | |
---|---|
2-METHYL-4-NITROBENZOIC ACID Cas:1975-51-5 | View Details |
(tert-Butoxycarbonyl)oxycefcapene pivoxil | View Details |
3-Amino-2-chlorobenzotrifluoride | View Details |